The largest database of trusted experimental protocols

Anti cd3 clone 2c11

Manufactured by R&D Systems
Sourced in United Kingdom, United States

The Anti-CD3 (clone 2C11) is a laboratory reagent used for the detection and identification of CD3, a protein complex found on the surface of T lymphocytes. This monoclonal antibody is directed against the CD3 epsilon chain, which is a critical component of the T cell receptor complex. The Anti-CD3 (clone 2C11) can be used in various immunological applications, such as flow cytometry, to study T cell function and activation.

Automatically generated - may contain errors

4 protocols using anti cd3 clone 2c11

1

Cytotoxic T Cell Adhesion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8 T cells (4x106/mL) were washed and resuspended in HEPES buffer (20 mM HEPES, 140 mM NaCl, 2g/L of glucose) with 0.1% BSA. Where required, 96-well flat-bottom flexiwell plates were coated with 10 μg/mL anti-CD3 (clone 2C11; R&D Systems) at 4°C O/N. T cell aliquots of 50 μL (2x105) were added to flexiwell plates (Dynatech, West Sussex, UK) with or without 5 mM Mg2+ and 1 mM EGTA. Soluble murine ICAM-1-Fc (10 μg/mL) was added to the cells in addition to 50 ng/mL PdBu, 100 μM N4 or 2 μg/mL anti-CD28 (R&D Systems). After 30 min incubation at 37°C, T cells were washed twice in ice-cold assay buffer with 0.1% BSA and incubated with 0.1 μg/mL of Fc-specific FITC-conjugated goat anti-human IgG (Jackson Immunoresearch, West Grove, PA) for 20 min on ice. Cells were washed twice in ice-cold assay buffer with 0.1% BSA to remove excess unbound mAb and fluorescence was detected with a MACSQUANT (Miltenyi Biotech) flow cytometer.
+ Open protocol
+ Expand
2

Generating Allogeneic iTregs for Immunotherapies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive CD4 T cells (CD4+Foxp3GFPCD44low) were sorted from lymph nodes of Foxp3GFP mice. For polyclonal iTreg generation, naive CD4 T cells were cultured with immobilized anti-CD3 (clone 2C11, 2 μg/ml), soluble anti-CD28 (clone 37.51, 2 μg/ml), rhIL-2 (100 U/ml) (obtained from the NCI Preclinical Repository Biological Resources Branch) and rhTGFβ1 (5 ng/ml, R&D system, Minneapolis, MN) for 3 days. For allogeneic iTreg generation, the sorted naive CD4 T cells were co-cultured with irradiated T cell-depleted splenocytes from BALB/c mice (2:1 ratio), rhIL-2 (100 U/ml), rhTGFβ1 (5 ng/ml), anti-CD3 (0.1 μg/ml) for 5 days (33 (link)). Tregs were sorted based on GFP expression and restimulated with immobilized anti-CD3 (2 μg/ml), anti-CD28 (2 μg/ml), rhIL-2 (100 U/ml) in the presence or absence of rIL-27 (10 ng/ml) for 24 h unless stated otherwise.
+ Open protocol
+ Expand
3

Activation-Dependent T Cell Adhesion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8 T cells (4 × 106/ml) were washed and resuspended in HEPES buffer (20 mM HEPES, 140 mM NaCl, 2 g/l glucose) with 0.1% BSA. Where required, 96-well flat-bottom flexiwell plates were coated with 10 μg/ml anti-CD3 (clone 2C11; R&D Systems) at 4°C overnight. T cell aliquots of 50 μl (2 × 105) were added to flexiwell plates (Dynatech, West Sussex, U.K.) with or without 5 mM Mg2+ and 1 mM EGTA. Soluble murine ICAM-1–Fc (10 μg/ml) was added to the cells in addition to 50 ng/ml PdBu, 100 μM N4, or 2 μg/ml anti-CD28 (R&D Systems). After 30 min incubation at 37°C, T cells were washed twice in ice-cold assay buffer with 0.1% BSA and incubated with 0.1 μg/ml Fc-specific FITC-conjugated goat anti-human IgG (Jackson ImmunoResearch Laboratories, West Grove, PA) for 20 min on ice. Cells were washed twice in ice-cold assay buffer with 0.1% BSA to remove excess unbound mAb and fluorescence was detected with a MACSQuant (Miltenyi Biotec) flow cytometer.
+ Open protocol
+ Expand
4

Effector T Cell Generation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Effector T cells were generated as in Lek et al. (4 (link)). Briefly, splenocytes from either wild-type (WT) or TTT/AAA- β2 integrin knock-in (KI) mice were activated with 0.5 μ g/ml anti-CD3 (clone 2C11, R&D Systems, Minneapolis, MN, USA) together with 20 ng/ml IL-2 (R&D Systems). After 2 days, cells were washed free of activating agent and then maintained in 20 ng/ml IL-2 to be used for experimental purposes on days 6–8 of the culture. Throughout the culture, cells were passaged every 2 days, as well as the day before use in an experiment, to ˜1 x 106 cells per ml.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!